期刊文献+

环氧合酶基因多态性与阿司匹林抵抗的关系 被引量:6

Correlation of Aspirin Resistance with Gene Polymorphisms of Cyclooxygenase
原文传递
导出
摘要 目的:研究缺血性脑卒中患者阿司匹林抵抗与血小板环氧合酶(COX)单核苷酸基因多态性(SNP)的相关性。方法:169位缺血性脑卒中患者服用阿司匹林100 mg/d至少7 d,根据血栓弹力图(TEG)检测结果分为阿司匹林敏感(AS)组和非阿司匹林敏感(NAS)组,并采用PCR产物直接测序分析法对患者的COX-1(-1676A>G)、COX-2(-765G>C)基因的单核苷酸多态性进行分析。结果:根据TEG检测结果,非阿司匹林敏感(NAS)组66例,阿司匹林敏感(AS)组103例。两组患者间COX-1基因-1676A>G SNP位点的基因型和等位基因频率分布差异具有统计学意义(P=0.016和P=0.008),特别是其等位基因频率分布具有显著差异。两组患者间COX-2基因-765G>C SNP位点的基因型和等位基因频率分布差异无统计学意义(P=0.084和P=0.090)。结论:COX-1基因-1676A>G位点多态性可能与缺血性脑卒中患者患者阿司匹林抵抗的发生相关,COX-2基因-765G>C位点多态性可能与阿司匹林抵抗的发生无关。 Objective: To explore the relationship between COX-1-1676AG,COX-2-765GC single nucleotide polymorphisms(SNP) and aspirin resistance in patients with Ischemic stroke.Methods: One hundred and sixty-nine patients with Ischemic stroke taking 100 mg aspirin at least 7 days were selected and divided into the aspirin sensitive group(AS) and non-aspirin sensitive group(NAS) according to thrombelastography(TEG).In these patients,COX-1-1676AG,COX-2-765GC gene polymorphisms were analyzed by polymerase chain reaction and DNA sequencing assay.Results: Patients were divided into NAS(66 cases) and AS(103 cases).There were significant differences in the genotype distribution and allele frequency of COX-1-1676AG SNP between two groups(P=0.016 and P=0.008).There were no significant difference in the genotype distribution and allele frequency of COX-2-765GC SNP between two groups(P=0.084 and P=0.090).Conclusion: In the patients with ischemic stroke,COX-1-1676AG polymorphism may be related to the aspirin resistance;however,COX-2-765GC polymorphism was not associated with the aspirin resistance.
出处 《现代生物医学进展》 CAS 2013年第17期3258-3262,共5页 Progress in Modern Biomedicine
基金 上海市崇明县科委基金项目(CK2011-31)
关键词 缺血性脑卒中 阿司匹林抵抗 血栓弹力图 基因多态性 环氧合酶 Ischemic stroke Aspirin resistance Thrombelastography Genetic polymorphism Cyclooxygenase
  • 相关文献

参考文献20

  • 1Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials[J]. Lancet,2009, 373(9678): 1849-1860. 被引量:1
  • 2Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs[J]. J Thromb Haemost,2003, I: 171 0-1713. 被引量:1
  • 3Hankey G J, Eikelboom J W. Aspirin Resistance [J]. Lancet,2006,367 (9 510):606-617. 被引量:1
  • 4Patrono C, Baigent C, Hirsh J, et al. Antiplatelet DrugsAmerican College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. CHEST Journal,2008,133(6_suppl):199S-233S. 被引量:1
  • 5Awtry E H, Loscalzo J. Aspirin[J]. Circulation,2000,101(10):1206-1218. 被引量:1
  • 6Antiplatelet Trialists' Collaboration. Collaborative overvention of death,myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients [J]. BMJ,1994,308:81-106. 被引量:1
  • 7Kuliczkowski W, Witkowski A, Polonski L, et al. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society ofCardiology[J]. Eur Heart,2009,30(4):426-435. 被引量:1
  • 8Wang T H, Bhatt D L, Topol E J. Aspirin and clopidogrel resistance: an emerging clinical entity[J]. Eur Heart J,2006,27(6):647-654. 被引量:1
  • 9Gum P A, Kottke-Marchant K, Poggio E D, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease [J]. Am J Cardiol,2001,88(3):230-235. 被引量:1
  • 10杨蓉,焦洁茹,林青,李嫣然,王熠华,徐志红,王学锋,丁秋兰,吴方.TEG对老年高血压患者阿司匹林疗效监测的研究[J].中国实验诊断学,2010,14(8):1205-1208. 被引量:8

二级参考文献11

  • 1Poston RS,White C,Gu J,et al.Aprotinin shows both hemostatic and a ntit hrombotice fectsd uringo ff-pumpc oronary artery bypass gra ftin g[J].A nnT homeS uing,2006,81 (1):104. 被引量:1
  • 2Marie Lordkipanidze,Chantal Pharand,Erick Schampaert,et al.A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery dis[J].European Heart Journal,2007,28:1702. 被引量:1
  • 3George KR,Stephanie JB,W Scott BE.Aspirin "resistance" and risk of cardiovascular morbidity:systematic review and meta-analysis[J].BMJ,2008,336:195. 被引量:1
  • 4Tantry US,Bliden KP,Gurbel PA.Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation[J].Am Coll Cardiol,2005 Nov 1,46(9):1705. 被引量:1
  • 5Carroll RC,Worthington RE,Craft RM,et al.Post interventional cardiology urinary thromboxane correlates with PlateletMapping(R) detected aspirin resistance[J].Thromb Res,2009,3. 被引量:1
  • 6Frelinger AL,Li Y,Linden MD,et al.Aspirin 'resistance':role of pre-existent platelet reactivity and correlation between tests[J].Thromb Haemost,2008,6(12):2035. 被引量:1
  • 7Rajec J,Kriska M,Vojtko R,et al.Biochemical evaluation of the antiplatelet effect of aspirin in patients at different levels of cardiovascular risk[J].Bratisl Lek Listy,2008,109(4):160. 被引量:1
  • 8Paul AG,Kevin PB,Joseph DiChiara,et al.Evaluation of Dose-Related Effects of Aspirin on Platelet Function.Result Form the Aspirin-Induced Platelet Effect(ASPECT)Study[J].Circulation,2007,115:3156. 被引量:1
  • 9EikelNoom Jw,Hirsh J,Weirz JI,et al.Aspirin-resisrant thromboxane biosynthesis and the risk of myocardial irdarction,stroke,or cardiovascular death in patients at hgh risk for cardiovascular events[J].Circulation,2002,105:1650. 被引量:1
  • 10Dobaczewski M,Nocun M,Zavodnik I,et al.Targeting the urine and plasma determinants of thromboxane A2 metabolism in detection of aspirin effectiveness[J].Blood Coagul Fibrinolysis,2008,19(5):421. 被引量:1

共引文献7

同被引文献103

  • 1赵勇,王建春,孙慧,王传霞,李元堂,尹承华,张杰,邵建华.环氧化酶-2基因-765G>C多态性与老年代谢综合征患者阿司匹林抵抗无关[J].中国分子心脏病学杂志,2011,11(3):164-168. 被引量:4
  • 2全锦花,张新超,蔡剑平,何青,许锋,戴大鹏.急性冠状动脉综合征患者血小板内皮细胞粘附分子1基因多态性分析[J].中国动脉硬化杂志,2007,15(2):120-124. 被引量:2
  • 3Gum PA,Kottke MK,Welsh PA. A prospective,blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease[J].{H}Journal of the America College of Cardiology,2003,(06):961-965. 被引量:1
  • 4Atique S,Bauman C,Seiji R,et al. Aspirin resistance and athero- thrombosis[J]. Braz J Cardiovasc Surg, 2007,22 : 96-103. 被引量:1
  • 5Antithromhotic Trialists(ATT) Collaboration, Batgent C, Black- well L,et al. Aspirin in the pcimary and accondary prevention of vascular disease;collaborative meta-analysis of individual partici- pant data from randomized trials[J]. Lancet, 2009,373: 1849- 1860. 被引量:1
  • 6Berger JS,Kranta M J, Kittelson JM, et a l. Aspirin for the pre- vention of cardiovascular events in patients with peripheral arter- y disease: a meta-analysis of randomized trials [J]. JAMA, 2009, 301(18) : 1909-1919. 被引量:1
  • 7Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2011 update:a report from the American Heart Association [J]. Circulation, 2011, 123(4) : 18-209. 被引量:1
  • 8Hankey GJ, Eikelboom JW. Aspirin Resistance [J]. Lancet, 2006, 367(9510): 606- 617. 被引量:1
  • 9Goodman T,Sharma F. The genetics of aspirin resistance[J]. Int J Clin Pract,2007,61 :826. 被引量:1
  • 10Timothy Goodman, lbert Ferro, ankaj Sharmal. Pharmacogenet- its of aspirin resistance:a comprehensive systematic review[J]. Br J Clin Pharmacol, 2008,66 : 222. 被引量:1

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部